{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:06:10Z","timestamp":1784037970711,"version":"3.55.0"},"reference-count":63,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2019.0047","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T07:02:34Z","timestamp":1547708554000},"source":"Crossref","is-referenced-by-count":15,"title":["Hypertrophic Obstructive Cardiomyopathy"],"prefix":"10.3238","author":[{"given":"Angelika","family":"Batzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin V.","family":"Borisov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Seggewi\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"10.3238\/arztebl.2019.0047_ref1","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force members, Elliott PM, Anastasakis A, et al.: 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733\u201379","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"10.3238\/arztebl.2019.0047_ref2","doi-asserted-by":"crossref","unstructured":"Nishimura RA, Holmes DR: Clinical practice. Hypertrophic obstructive cardiomyopathy. N Engl J Med 2004; 350: 1320\u20137","DOI":"10.1056\/NEJMcp030779"},{"key":"10.3238\/arztebl.2019.0047_ref3","doi-asserted-by":"crossref","unstructured":"Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults. Circulation 1995; 92: 785\u20139","DOI":"10.1161\/01.CIR.92.4.785"},{"key":"10.3238\/arztebl.2019.0047_ref4","doi-asserted-by":"crossref","unstructured":"Semsarian C, Ingles J, Maron MS, Maron BJ: New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015; 65: 1249\u201354","DOI":"10.1016\/j.jacc.2015.01.019"},{"key":"10.3238\/arztebl.2019.0047_ref5","unstructured":"Koljaja-Batzner A, Pfeiffer B, Seggewiss H: Die hypertrophe Kardiomyopathie \u2013 h\u00e4ufig und nicht erkannt. Internistische Praxis 2018; 59: 187\u2013201."},{"key":"10.3238\/arztebl.2019.0047_ref6","unstructured":"Seggewiss H, Koljaja-Batzner A, Seggewiss K, Meesmann M: [Syncope in hypertrophic (obstructive) cardiomyopathy]. Herzschrittmacherther Elektrophysiol 2018; 29: 141\u20133"},{"key":"10.3238\/arztebl.2019.0047_ref7","doi-asserted-by":"crossref","unstructured":"Maron BJ: Sudden death in hypertrophic cardiomyopathy. J Cardiovasc Transl Res 2009; 2: 368\u201380","DOI":"10.1007\/s12265-009-9147-0"},{"key":"10.3238\/arztebl.2019.0047_ref8","doi-asserted-by":"crossref","unstructured":"Maron BJ, Epstein SE, Roberts WC: Hypertrophic cardiomyopathy: a common cause of sudden death in the young competitive athlete. Eur Heart J 1983; 4(Suppl F): 135\u201344","DOI":"10.1093\/eurheartj\/4.suppl_F.135"},{"key":"10.3238\/arztebl.2019.0047_ref9","doi-asserted-by":"crossref","unstructured":"Maron MS, Olivotto I, Zenovich AG, et al.: Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006; 114: 2232\u20139","DOI":"10.1161\/CIRCULATIONAHA.106.644682"},{"key":"10.3238\/arztebl.2019.0047_ref10","doi-asserted-by":"crossref","unstructured":"Prinz C, Farr M, Hering D, Horstkotte D, Faber L: The diagnosis and treatment of hypertrophic cardiomyopathy. Dtsch Arztebl Int 2011; 108: 209\u201315","DOI":"10.3238\/arztebl.2011.0209"},{"key":"10.3238\/arztebl.2019.0047_ref11","doi-asserted-by":"crossref","unstructured":"Schaff HV, Dearani JA, Ommen SR, Sorajja P, Nishimura RA: Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction. J Thorac Cardiovasc Surg 2012; 143: 303\u20139","DOI":"10.1016\/j.jtcvs.2011.10.059"},{"key":"10.3238\/arztebl.2019.0047_ref12","doi-asserted-by":"crossref","unstructured":"Sherrid MV: Pathophysiology and treatment of hypertrophic cardiomyopathy. Prog Cardiovasc Dis 2006; 49: 123\u201351","DOI":"10.1016\/j.pcad.2006.08.001"},{"key":"10.3238\/arztebl.2019.0047_ref13","doi-asserted-by":"crossref","unstructured":"Wigle ED, Sasson Z, Henderson MA, et al.: Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985; 28: 1\u201383","DOI":"10.1016\/0033-0620(85)90024-6"},{"key":"10.3238\/arztebl.2019.0047_ref14","doi-asserted-by":"crossref","unstructured":"Goel K, Schaff HV, Nishimura RA: Natural history of apical hypertrophic cardiomyopathy and novel surgical treatment. J Thorac Cardiovasc Surg 2016; 152: 626\u20137","DOI":"10.1016\/j.jtcvs.2016.03.017"},{"key":"10.3238\/arztebl.2019.0047_ref15","doi-asserted-by":"crossref","unstructured":"Marian AJ, Braunwald E: Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 2017; 121: 749\u201370","DOI":"10.1161\/CIRCRESAHA.117.311059"},{"key":"10.3238\/arztebl.2019.0047_ref16","unstructured":"American College of Cardiology Foundation\/American Heart Association Task Force on Parctice, American Association for Thoracic Surgery, American Society of Echocardiography, et al.: 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2011; 142: e153\u2013e203"},{"key":"10.3238\/arztebl.2019.0047_ref17","doi-asserted-by":"crossref","unstructured":"O\u2018Mahony C, Jichi F, Pavlou M, et al.: A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 2014; 35: 2010\u201320","DOI":"10.1093\/eurheartj\/eht439"},{"key":"10.3238\/arztebl.2019.0047_ref18","doi-asserted-by":"crossref","unstructured":"Seggewiss H, Faber L: Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction. Eur J Echocardiogr 2000; 1: 277\u201380","DOI":"10.1053\/euje.2000.0032"},{"key":"10.3238\/arztebl.2019.0047_ref19","doi-asserted-by":"crossref","unstructured":"Nishimura RA, Seggewiss H, Schaff HV: Hypertrophic obstructive cardiomyopathy: surgical myectomy and septal ablation. Circ Res 2017; 121: 771\u201383","DOI":"10.1161\/CIRCRESAHA.116.309348"},{"key":"10.3238\/arztebl.2019.0047_ref20","doi-asserted-by":"crossref","unstructured":"Morrow AG, Brockenbrough EC: Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg 1961; 154: 181\u20139","DOI":"10.1097\/00000658-196108000-00003"},{"key":"10.3238\/arztebl.2019.0047_ref21","doi-asserted-by":"crossref","unstructured":"Messmer BJ: Extended myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 1994; 58: 575\u20137","DOI":"10.1016\/0003-4975(94)92268-3"},{"key":"10.3238\/arztebl.2019.0047_ref22","doi-asserted-by":"crossref","unstructured":"Maron BJ, Dearani JA, Ommen SR, et al.: Low operative mortality achieved with surgical septal myectomy: role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction. J Am Coll Cardiol 2015; 66: 1307\u20138","DOI":"10.1016\/j.jacc.2015.06.1333"},{"key":"10.3238\/arztebl.2019.0047_ref23","doi-asserted-by":"crossref","unstructured":"Kim LK, Swaminathan RV, Looser P, et al.: Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003\u20132011. JAMA Cardiol 2016; 1: 324\u201332","DOI":"10.1001\/jamacardio.2016.0252"},{"key":"10.3238\/arztebl.2019.0047_ref24","unstructured":"Mohr R, Schaff HV, Puga FJ, Danielson GK: Results of operation for hypertrophic obstructive cardiomyopathy in children and adults less than 40 years of age. Circulation 1989; 80: I191\u20136"},{"key":"10.3238\/arztebl.2019.0047_ref25","doi-asserted-by":"crossref","unstructured":"Ball W, Ivanov J, Rakowski H, et al.: Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. J Am Coll Cardiol 2011; 58: 2313\u201321","DOI":"10.1016\/j.jacc.2011.08.040"},{"key":"10.3238\/arztebl.2019.0047_ref26","doi-asserted-by":"crossref","unstructured":"McLeod CJ, Ommen SR, Ackerman MJ, et al.: Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J 2007; 28: 2583\u20138","DOI":"10.1093\/eurheartj\/ehm117"},{"key":"10.3238\/arztebl.2019.0047_ref27","doi-asserted-by":"crossref","unstructured":"Brugada P, de Swart H, Smeets JL, Wellens HJ: Transcoronary chemical ablation of ventricular tachycardia. Circulation 1989; 79: 475\u201382","DOI":"10.1161\/01.CIR.79.3.475"},{"key":"10.3238\/arztebl.2019.0047_ref28","doi-asserted-by":"crossref","unstructured":"Sigwart U: Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 346: 211\u20134","DOI":"10.1016\/S0140-6736(95)91267-3"},{"key":"10.3238\/arztebl.2019.0047_ref29","doi-asserted-by":"crossref","unstructured":"Geske JB, Gersh BJ: Myectomy versus alcohol septal ablation: experience remains key. JACC Cardiovasc Interv 2014; 7: 1235\u20136","DOI":"10.1016\/j.jcin.2014.05.022"},{"key":"10.3238\/arztebl.2019.0047_ref30","doi-asserted-by":"crossref","unstructured":"Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S: Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998; 31: 252\u20138","DOI":"10.1016\/S0735-1097(97)00508-1"},{"key":"10.3238\/arztebl.2019.0047_ref31","doi-asserted-by":"crossref","unstructured":"Gietzen FH, Leuner CJ, Raute-Kreinsen U, et al.: Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 1999; 20: 1342\u201354","DOI":"10.1053\/euhj.1999.1520"},{"key":"10.3238\/arztebl.2019.0047_ref32","doi-asserted-by":"crossref","unstructured":"Gleichmann U, Seggewiss H, Faber L, Fassbender D, Schmidt HK, Strick S: [Catheter treatment of hypertrophic obstructive cardiomyopathy]. Dtsch Med Wochenschr 1996; 121: 679\u201385","DOI":"10.1055\/s-2008-1043055"},{"key":"10.3238\/arztebl.2019.0047_ref33","doi-asserted-by":"crossref","unstructured":"Faber L, Seggewiss H, Gleichmann U: Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998; 98: 2415\u201321","DOI":"10.1161\/01.CIR.98.22.2415"},{"key":"10.3238\/arztebl.2019.0047_ref34","doi-asserted-by":"crossref","unstructured":"Veselka J, Jensen MK, Liebregts M, et al.: Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry. Eur Heart J 2016; 37: 1517\u201323","DOI":"10.1093\/eurheartj\/ehv693"},{"key":"10.3238\/arztebl.2019.0047_ref35","doi-asserted-by":"crossref","unstructured":"Sorajja P, Binder J, Nishimura RA, et al.: Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv 2013; 81: E58\u2013E67","DOI":"10.1002\/ccd.24328"},{"key":"10.3238\/arztebl.2019.0047_ref36","doi-asserted-by":"crossref","unstructured":"Nagueh SF, Groves BM, Schwartz L, et al.: Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol 2011; 58: 2322\u20138","DOI":"10.1016\/j.jacc.2011.06.073"},{"key":"10.3238\/arztebl.2019.0047_ref37","doi-asserted-by":"crossref","unstructured":"Jensen MK, Prinz C, Horstkotte D, et al.: Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile. Heart 2013; 99: 1012\u20137","DOI":"10.1136\/heartjnl-2012-303339"},{"key":"10.3238\/arztebl.2019.0047_ref38","doi-asserted-by":"crossref","unstructured":"Koljaja-Batzner A, Pfeiffer B, Neugebauer A, Aicha D, Blank C, Seggewiss H: Long-term survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2018; 72: 3087\u201394.","DOI":"10.1016\/j.jacc.2018.09.064"},{"key":"10.3238\/arztebl.2019.0047_ref39","doi-asserted-by":"crossref","unstructured":"Liebregts M, Steggerda RC, Vriesendorp PA, et al.: Long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in the young and the elderly. JACC Cardiovasc Interv 2016; 9: 463\u20139","DOI":"10.1016\/j.jcin.2015.11.036"},{"key":"10.3238\/arztebl.2019.0047_ref40","doi-asserted-by":"crossref","unstructured":"Singh K, Qutub M, Carson K, Hibbert B, Glover C: A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv 2016; 88: 107\u201315","DOI":"10.1002\/ccd.26293"},{"key":"10.3238\/arztebl.2019.0047_ref41","doi-asserted-by":"crossref","unstructured":"Maron BJ, Maron MS: Hypertrophic cardiomyopathy. Lancet 2013; 381: 242\u201355","DOI":"10.1016\/S0140-6736(12)60397-3"},{"key":"10.3238\/arztebl.2019.0047_ref42","doi-asserted-by":"crossref","unstructured":"Braunwald E, Lambrew CT, Rockoff SD, Ross J, Jr., Morrow AG: Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964; 30 (Suppl 4): 3\u2013119.","DOI":"10.1161\/01.CIR.29.5S4.IV-3"},{"key":"10.3238\/arztebl.2019.0047_ref43","doi-asserted-by":"crossref","unstructured":"Wigle ED, David PR, Labroose CJ, McMeekan J: Muscular subaortic stenosis; the interrelation of wall tension, outflow tract \u201edistending pressure\u201c and orifice radius. Am J Cardiol 1965; 15: 761\u201372","DOI":"10.1016\/0002-9149(65)90378-4"},{"key":"10.3238\/arztebl.2019.0047_ref44","doi-asserted-by":"crossref","unstructured":"Nishimura RA, Ommen SR: Hypertrophic cardiomyopathy: the search for obstruction. Circulation 2006; 114: 2200\u20132","DOI":"10.1161\/CIRCULATIONAHA.106.660928"},{"key":"10.3238\/arztebl.2019.0047_ref45","unstructured":"Brock R: Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis. Guys Hosp Rep 1957; 106: 221\u201338"},{"key":"10.3238\/arztebl.2019.0047_ref46","doi-asserted-by":"crossref","unstructured":"Shah PM, Gramiak R, Kramer DH: Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 1969; 40: 3\u201311","DOI":"10.1161\/01.CIR.40.1.3"},{"key":"10.3238\/arztebl.2019.0047_ref47","doi-asserted-by":"crossref","unstructured":"Nishimura RA, Tajik AJ, Reeder GS, Seward JB: Evaluation of hypertrophic cardiomyopathy by Doppler color flow imaging: initial observations. Mayo Clin Proc 1986; 61: 631\u20139","DOI":"10.1016\/S0025-6196(12)62027-8"},{"key":"10.3238\/arztebl.2019.0047_ref48","doi-asserted-by":"crossref","unstructured":"Wigle ED: Hypertrophic cardiomyopathy: a 1987 viewpoint. Circulation 1987; 75: 311\u201322","DOI":"10.1161\/01.CIR.75.2.311"},{"key":"10.3238\/arztebl.2019.0047_ref49","doi-asserted-by":"crossref","unstructured":"Nishimura RA, Trusty JM, Hayes DL, et al.: Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997; 29: 435\u201341","DOI":"10.1016\/S0735-1097(96)00473-1"},{"key":"10.3238\/arztebl.2019.0047_ref50","doi-asserted-by":"crossref","unstructured":"Ashikhmina EA, Schaff HV, Ommen SR, Dearani JA, Nishimura RA, Abel MD: Intraoperative direct measurement of left ventricular outflow tract gradients to guide surgical myectomy for hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 2011; 142: 53\u20139","DOI":"10.1016\/j.jtcvs.2010.08.011"},{"key":"10.3238\/arztebl.2019.0047_ref51","doi-asserted-by":"crossref","unstructured":"Rowin EJ, Maron BJ, Lesser JR, Rastegar H, Maron MS: Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management. Am J Cardiol 2013; 111: 1677\u20139","DOI":"10.1016\/j.amjcard.2013.01.340"},{"key":"10.3238\/arztebl.2019.0047_ref52","doi-asserted-by":"crossref","unstructured":"Klarich KW, Attenhofer Jost CH, Binder J, et al.: Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. Am J Cardiol 2013; 111: 1784\u201391","DOI":"10.1016\/j.amjcard.2013.02.040"},{"key":"10.3238\/arztebl.2019.0047_ref53","unstructured":"Morrow AG: Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg 1978; 76: 423\u201330"},{"key":"10.3238\/arztebl.2019.0047_ref54","doi-asserted-by":"crossref","unstructured":"Maron BJ, Nishimura RA: Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014. Circulation 2014; 130: 1617\u201324","DOI":"10.1161\/CIRCULATIONAHA.114.011580"},{"key":"10.3238\/arztebl.2019.0047_ref55","doi-asserted-by":"crossref","unstructured":"Desai MY, Smedira NG, Bhonsale A, Thamilarasan M, Lytle BW, Lever HM: Symptom assessment and exercise impairment in surgical decision making in hypertrophic obstructive cardiomyopathy: relationship to outcomes. J Thorac Cardiovasc Surg 2015; 150: 928\u201335 e1","DOI":"10.1016\/j.jtcvs.2015.07.063"},{"key":"10.3238\/arztebl.2019.0047_ref56","doi-asserted-by":"crossref","unstructured":"Sigwart U, Grbic M, Essinger A, Bischof-Delaloye A, Sadeghi H, Rivier JL: Improvement of left ventricular function after percutaneous transluminal coronary angioplasty. Am J Cardiol 1982; 49: 651\u20137","DOI":"10.1016\/0002-9149(82)91942-7"},{"key":"10.3238\/arztebl.2019.0047_ref57","doi-asserted-by":"crossref","unstructured":"Come PC, Riley MF: Hypertrophic cardiomyopathy. Disappearance of auscultatory, carotid pulse, and echocardiographic manifestations of obstruction following myocardial infarction. Chest 1982; 82: 451\u20134","DOI":"10.1378\/chest.82.4.451"},{"key":"10.3238\/arztebl.2019.0047_ref58","doi-asserted-by":"crossref","unstructured":"Goodwin JF, Oakley CM: Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 346: 1624","DOI":"10.1016\/S0140-6736(95)91954-6"},{"key":"10.3238\/arztebl.2019.0047_ref59","doi-asserted-by":"crossref","unstructured":"Maron BJ: Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287: 1308\u201320","DOI":"10.1001\/jama.287.10.1308"},{"key":"10.3238\/arztebl.2019.0047_ref60","doi-asserted-by":"crossref","unstructured":"Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS: Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol 2014; 64: 83\u201399","DOI":"10.1016\/j.jacc.2014.05.003"},{"key":"10.3238\/arztebl.2019.0047_ref61","doi-asserted-by":"crossref","unstructured":"Alam M, Dokainish H, Lakkis N: Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol 2006; 19: 319\u201327","DOI":"10.1111\/j.1540-8183.2006.00153.x"},{"key":"10.3238\/arztebl.2019.0047_ref62","doi-asserted-by":"crossref","unstructured":"Seggewiss H, Rigopoulos A, Welge D, Ziemssen P, Faber L: Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol 2007; 96: 856\u201363","DOI":"10.1007\/s00392-007-0579-8"},{"key":"10.3238\/arztebl.2019.0047_ref63","doi-asserted-by":"crossref","unstructured":"Steggerda RC, Damman K, Balt JC, Liebregts M, ten Berg JM, van den Berg MP: Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience. JACC Cardiovasc Interv 2014; 7: 1227\u201334","DOI":"10.1016\/j.jcin.2014.05.023"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2019.0047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T12:34:27Z","timestamp":1662813267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2019.0047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":63,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2019.0047","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]}}}